Aurobindo Pharma USA Inc. is recalling 115,776 bottles of Moxifloxacin Ophthalmic Solution, USP 0.5% (3 mL). This prescription antibiotic eye drop is being recalled because testing revealed that the product failed to meet standard specifications for impurities or degradation. No incidents or injuries have been reported to date, but patients should consult with a healthcare professional regarding their treatment.
The presence of impurities or degradation products beyond approved limits can reduce the medication's effectiveness or potentially cause unexpected side effects during use. No injuries have been reported in connection with this specific recall.
You have 2 options:
Distributed by Aurobindo Pharma USA, Inc., East Windsor, NJ 08520.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.